COVID-19 mRNA vaccines: a prospective outlook from technological innovation to clinical practice - Top-Institutions - MDSpire

COVID-19 mRNA vaccines: a prospective outlook from technological innovation to clinical practice

  • By

  • Junqi Ma

  • Huoying Chen

  • Yunyi He

  • Yuye Huang

  • Xianlong Duan

  • Qiliang Liu

  • Zheng Liu

  • Hongbo Liu

  • June 4, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    University of Pennsylvania
    University of Pennsylvania

    Philadelphia, Pennsylvania

    Key Differentiators

    • Infectious Disease
    • Vaccinology

  • #2

    National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Research Center
    National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Research Center

    Bethesda, Maryland

    Key Differentiators

    • Infectious Disease
    • Vaccine Research

Original Source(s)

COVID-19 mRNA vaccines: a prospective outlook from technological innovation to clinical practice

  • by Junqi Ma, Huoying Chen, Yunyi He, Yuye Huang, Xianlong Duan, Qiliang Liu, Zheng Liu, Hongbo Liu

  • June 4, 2026

Related Content

Sustaining herd immunity against measles: Insights from a serological cohort study in an outbreak-free population

Top 10 States With Rising Demand for Physicians

These 10 states report physician shortages, projected physician supply gaps, or physician-to-population ratios below national benchmarks.

Progress and prospects for herpesvirus vaccination using gB antigens